IMPORTANT INVESTOR NOTICE: Goldberg Law PC Announces An Investigation of Claims Against TriNet Group, Inc. And Strongly Encourages Investors With Losses To Contact The Firm

LOS ANGELES--(BUSINESS WIRE)-- Goldberg Law PC (http://www.Goldberglawpc.com) announces that it is investigating claims of potential misrepresentations by TriNet Group, Inc. (“TriNet” or the “Company”) (NYSE: TNET). The investigation focuses on whether the Company and its officers violated securities laws by issuing misleading information to investors.

If you purchased or otherwise acquired TriNet shares and would like more information regarding the investigation, we advise you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 13650 Marina Pointe Dr. Suite 708, Marina Del Rey, CA 90292, at 800-977-7401, to discuss your rights without cost to you. You can also reach us through the firm’s website at http://www.Goldberglawpc.com, or by email at [email protected].

The investigation concerns whether the Company violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. Specifically, the investigation will focus on the Company’s March 1, 2016, disclosure that the Company had discovered material weaknesses in its internal controls. The Company is now seeking an extension for filing their 10-K with the SEC.

If you have any questions concerning your legal rights in this potential case, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at [email protected].

Goldberg Law PC represents shareholders around the world and specializes in securities class actions and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160301007156/en/

Goldberg Law PC, Los Angeles
Michael Goldberg, Esq., 800-977-7401
Brian Schall, Esq., 800-977-7401
[email protected]
http://www.Goldberglawpc.com
https://twitter.com/search?q=goldberglawpc&src=typd
https://www.facebook.com/pages/Goldberg-Law-PC/850505465033804?fref=ts

Source: Goldberg Law PC

You May Also Be Interested In

• FDA clears Merck's Keytruda combo for muscle-invasive bladder cancer
• FDA approves Padcev plus Keytruda for muscle-invasive bladder cancer
• Yimutian gets approval to transfer to Nasdaq Capital Market